Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Forian Inc. (FORA:NASDAQ), powered by AI.
Forian Inc. is currently trading at $2.78. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Forian Inc. on Alpha Lenz.
Forian Inc.'s P/E ratio is -30.1.
“Forian Inc. trades at a P/E of -30.1 (undervalued) with modest ROE of -9.6%. 3Y revenue CAGR of 22.6% highlights clear growth momentum.”
Ask for details →Forian Inc. is a comprehensive data and analytics company that delivers integrated solutions to the healthcare and cannabis industries. The company's primary function is to provide actionable intelligence and data-driven insights that enhance operational efficiencies, optimize patient outcomes, and support strategic business decisions. By leveraging its proprietary technology platform, Forian Inc. bridges the gap between healthcare and cannabis sectors, facilitating enhanced regulatory compliance and strategic growth opportunities. Notable features of Forian's offerings include advanced analytics, market research, and information management solutions tailored specifically for clients in the pharmaceutical, biotechnology, and legal cannabis markets. In the financial market, Forian Inc. occupies a unique niche, serving as a critical partner for businesses within emerging and regulated industries, helping streamline operations and fostering innovation. Its role is pivotal in supporting industry stakeholders by providing comprehensive data services and technology that drive informed decision-making and competitive advantage.
“Forian Inc. trades at a P/E of -30.1 (undervalued) with modest ROE of -9.6%. 3Y revenue CAGR of 22.6% highlights clear growth momentum.”
Ask for details →Forian Inc. (ticker: FORA) is a company listed on NASDAQ in the Healthcare sector (Health Information Services). It has approximately 47 employees. Market cap is $86M.
The current price is $2.78 with a P/E ratio of -30.09x and P/B of 2.9x.
ROE is -9.61% and operating margin is -8.16%. Annual revenue is $30M.